Back

Sotatercept improves echocardiographic risk stratification in pulmonary arterial hypertension: real-world data from the french early access program

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy and the spectrum of left ventricular hypertrophy Morphology, Dimensions, Volumes and Mass ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Manel EL BLIDI

Hospital Kremlin Bicetre, Le Kremlin-Bicetre (France)

5 More presentations in this session

Presentation thumbnail
Atrial reverse remodelling and restored atrioventricular coupling define diastolic recovery during mavacamten therapy in obstructive hypertrophic cardiomyopathy
Doctor P. Craciun (Bucharest, RO) Miss S. Gonzalez De Alaiza (ES)
Abstract Slides Video
Presentation thumbnail
Diastolic reserve restoration drives functional improvement under mavacamten in obstructive hypertrophic cardiomyopathy: a real-world CPET–echocardiography study
Mr J. Broustaille (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Predicting five-year mortality in patients with left ventricular hypertrophy based on dynamic radiomics from transthoracic echocardiography
Mr P. Su (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Systematic misclassification of left ventricular mass by echocardiography is driven by ventricular geometry: a CT-based reference analysis
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Mavacamten improves left ventricular systolic synchrony in obstructive hypertrophic cardiomyopathy: real-world data from China
Miss W. Liang (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy and the spectrum of left ventricular hypertrophy

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Quick and sustained right ventricular reverse remodeling at early, mid and late follow-Up under sotatercept
30 August 2026
thumbnail
Congress Presentation
Discordance between PAH risk scores in systemic sclerosis–associated pulmonary arterial hypertension
30 August 2026
thumbnail
Congress Presentation
Prognostic impact of integrated echocardiographic and electrocardiographic staging of atrial cardiomyopathy in severe aortic stenosis undergoing TAVI
30 August 2026
thumbnail
Congress Presentation
AI detection of calcification in the aortic valve and coronary arteries independently predicts mortality beyond COMPERA 2.0 and REVEAL 2.0 scores in PAH and CTEPH
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources